USFDA Issues Warning to Granules India Over Critical Manufacturing Violations at Telangana Facility
The US Food and Drug Administration has issued a warning letter to Granules India citing serious contamination issues and inadequate maintenance at its Telangana formulations plant following an inspection conducted in August-September 2024.
FDA Issues Warning Letter to Granules India for GMP Violations at Telangana Facility
The U.S. Food and Drug Administration has issued a warning letter to Granules India citing significant Good Manufacturing Practice (GMP) violations at its Telangana manufacturing plant.